Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Patent 12071485 was granted and assigned to Avidity Biosciences on August, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 28 Aug, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 28 Aug, 2024
Edits made to:
Infobox (+101 properties)
Article (+164 characters)
‌

 US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Article

Patent abstract

Disclosed herein are polynucleic acid molecules, pharmaceutical compositions, and methods for treating facioscapulohumeral muscular dystrophy (FSHD).

Infobox
Is a
Patent
Patent
0
Patent Applicant
Avidity Biosciences
Avidity Biosciences
0
Current Assignee
Avidity Biosciences
Avidity Biosciences
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
120714850
Patent Inventor Names
Barbora Malecova0
Beatrice Diana Darimont0
David Sala Cano0
Rob Burke0
Date of Patent
August 27, 2024
0
Patent Application Number
184025960
Date Filed
January 2, 2024
0
Patent Citations
‌
US Patent 11111309 Method of reducing expression of DUX4 in a muscle cell by administering an anti-transferrin receptor antibody linked to an oligonucleotide targeting DUX4
0
‌
US Patent 7132519 Releasable nonvolatile mass-label molecules
0
‌
US Patent 7244724 Pyrrolobenzodiazepines
0
‌
US Patent 7276497 Cytotoxic agents comprising new maytansinoids
0
‌
US Patent 7452987 Interfering RNA molecules
0
‌
US Patent 7498298 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 7521232 Emissive species for clinical imaging
0
‌
US Patent 7528126 Pyrrolobenzodiazepines
0
‌
US Patent 7595387 Modified polynucleotides for reducing off-target effects in RNA interference
0
‌
US Patent 7612062 Pyrrolobenzodiazepines
0
‌
US Patent 7659241 Drug conjugates and their use for treating cancer, an autoimmune disease or an infectious disease
0
‌
US Patent 7704924 Library of compounds comprising pyrrolobenzodiazepine moieties
0
‌
US Patent 7709226 Method of humanizing antibodies by matching canonical structure types CDRs
0
‌
US Patent 7750116 Antibody drug conjugate metabolites
0
‌
US Patent 7833992 Conjugates and compositions for cellular delivery
0
‌
US Patent 7834171 Modified polynucleotides for reducing off-target effects in RNA interference
0
‌
US Patent 7850975 Chemically programmable immunity
0
‌
US Patent 7893245 Interfering RNA molecules
0
‌
US Patent 7923547 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 7943762 Oligonucleotide analogs having cationic intersubunit linkages
0
‌
US Patent 7964566 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 8084598 Bioionformality detectable group of novel regulatory oligonucleotides and uses thereof
0
‌
US Patent 8090542 Functional and hyperfunctional siRNA
0
‌
US Patent 8137695 Polyconjugates for in vivo delivery of polynucleotides
0
‌
US Patent 8163736 Cytotoxic agents comprising new tomaymycin derivatives
0
‌
US Patent 8202979 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid
0
‌
US Patent 8273866 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (SINA)
0
‌
US Patent 8288352 Auristatins having an aminobenzoic acid unit at the N terminus
0
‌
US Patent 8324370 Interfering RNA molecules
0
‌
US Patent 8389710 Therapeutic nucleic acid-3′-conjugates
0
‌
US Patent 8404678 Cytotoxic agents comprising new tomaymycin derivatives and their therapeutic use
0
‌
US Patent 8426402 Benzodiazepine derivatives
0
‌
US Patent 8481698 Parallel proximity ligation event analysis
0
‌
US Patent 8501934 Pyrrolobenzodiazepines
0
‌
US Patent 8580820 Tubulysin compounds with high cytotoxicity, pharmaceutical compositions thereof, and method of use thereof
0
‌
US Patent 8591910 Chemically programmable immunity
0
‌
US Patent 8604184 Chemically programmable immunity
0
‌
US Patent 8609105 Auristatin drug linker conjugates
0
‌
US Patent 8618277 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 8633185 Pyrrolobenzodiazepines
0
‌
US Patent 8648185 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 8697688 Pyrrolobenzodiazepines used to treat proliferative diseases
0
‌
US Patent 8703714 Monomethylvaline compounds capable of conjugation to ligands
0
‌
US Patent 8802667 Benzodiazepine derivatives
0
‌
US Patent 8809320 Benzodiazepine derivatives
0
‌
US Patent 8846875 Preparation and/or purification of oligonucleotide conjugates
0
‌
US Patent 8871720 Monomethylvaline compounds having phenylalanine carboxy modifications at the C-terminus
0
‌
US Patent 8906847 Prodrug comprising a drug linker conjugate
0
‌
US Patent 8933215 Interfering RNA molecules
0
‌
US Patent 8936910 Method for selective oligonucleotide modification
0
‌
US Patent 8980833 Tubulysine derivatives
0
‌
US Patent 9089614 Hydrophilic self-immolative linkers and conjugates thereof
0
‌
US Patent 9181551 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9222092 Interfering RNA molecules
0
‌
US Patent 9242013 Targeted pyrrolobenzodiazapine conjugates
0
‌
US Patent 9243252 Oligomers
0
‌
US Patent 9260471 RNA interference mediated inhibition of gene expression using short interfering nucleic acids (siNA)
0
‌
US Patent 9328345 Compositions of asymmetric interfering RNA and uses thereof
0
‌
US Patent 9364553 Synergistic biomolecule-polymer conjugates
0
‌
US Patent 9481905 Method of using neutrilized DNA (N-DNA) as surface probe for high throughput detection platform
0
‌
US Patent 9499818 Methods and means for efficient skipping of at least one of the exons 51-53, 55, 57 and 59 of the human duchenne muscular dystrophy gene
0
‌
US Patent 9605019 Methods for the synthesis of functionalized nucleic acids
0
‌
US Patent 9657294 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9695211 Method for the synthesis of phosphorus atom modified nucleic acids
0
‌
US Patent 9695423 Interfering RNA molecules
0
‌
US Patent 9708406 Anti-transferrin receptor antibodies and methods of use
0
‌
US Patent 9732344 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9771588 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 9796974 Modified RNAi agents
0
‌
US Patent 9890379 Treatment of genetic disorders associated with DNA repeat instability
0
‌
US Patent 9982257 Chiral control
0
‌
US Patent 10000754 RNA interference mediated inhibition of gene expression using chemically modified short interfering nucleic acid (siNA)
0
‌
US Patent 10087210 Modified nucleosides, analogs thereof and oligomeric compounds prepared therefrom
0
‌
US Patent 10323089 Anti-transferrin receptor antibodies with tailored affinity
0
‌
US Patent 10612027 Modified double-stranded RNA agents
0
‌
US Patent 10865445 Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL
0
‌
US Patent 10881743 Compositions and methods of treating muscle atrophy and myotonic dystrophy
0
‌
US Patent 10994020 Nucleic acid-polypeptide compositions and methods of inducing exon skipping
0
‌
US Patent 11286305 Complex comprising anti-transferrin receptor antibody covalently linked to an oligonucleotide that targets DUX4 RNA
0
‌
US Patent 11504391 Modified RNA agents with reduced off-target effect
0
‌
US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
0
‌
US Patent 11555190 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
0
‌
US Patent 11638761 Muscle targeting complexes and uses thereof for treating Facioscapulohumeral muscular dystrophy
0
‌
US Patent 6849272 Endosomolytic agents and cell delivery systems
0
‌
US Patent 6884869 Pentapeptide compounds and uses related thereto
0
‌
US Patent 6942972 Efficient synthesis of protein-oligonucleotide conjugates
0
‌
US Patent 7049311 Pyrrolbenzodiazepines
0
‌
US Patent 7067511 Pyrrolobenzodiazepines
0
Patent Primary Examiner
‌
Ruixiang Li
0

Find more entities like US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.